Tyra Biosciences

📍 Carlsbad, United States👥 58 employees💰 Last funded Jan 2020
Biotechnology🌐 tyra.bio
Website LinkedIn
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Companys in-house precision medicine platform, SNÅP, enables the rapid and precise refinement of structural drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRAs initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. TYRA is based in Carlsbad, CA.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Tyra Biosciences?
Tyra Biosciences has 1 investors on record on gritt.io.
When did Tyra Biosciences last raise funding?
The most recent investment in Tyra Biosciences recorded on gritt.io was in January 2020.
What industry is Tyra Biosciences in?
Tyra Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Tyra Biosciences based?
Tyra Biosciences is headquartered in Carlsbad, United States.